Granted Patent
B2
US 7,939,511 · App. 11/663,771 · Granted May 10, 2011
Ophthalmic composition containing xanthan gum and amino acid
Assignee:
Senju Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides an ophthalmic composition containing xanthan gum, or xanthan gum and an amino acid, which has a superior corneal epithelial disorder-treating effect and a superior corneal epithelial cell-protecting effect.
Claims (2)
1. An ophthalmic composition comprising xanthan gum, and L-aspartate or a pharmacologically acceptable salt thereof, wherein the concentration of the xanthan gum is 0.05-0.4 w/v % and wherein the concentration of the L-aspartate or a pharmacologically acceptable salt thereof is 0.05-1 w/v %.
2. The ophthalmic composition of claim 1 , which is an eye drop.
Assignments (2)
CHANGE OF ADDRESS
Recorded Aug 24, 2018
From: SENJU PHARMACEUTICAL CO., LTD.
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 046835/0350 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 11, 2007
From: DOI, KOJI; AKI, HIROSHI
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 019179/0866 →
Priority Claims (1)
JP 2004-281588
· Sep 28, 2004
· national
Continuity (1)